RNU6-1236P

Across TCGA pan-cancer cohorts, RNU6-1236P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-1236P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-1236P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1236P expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

STAD, LAML, and KIRC are the cancer types where RNU6-1236P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.119	0.558	<.001	45	view →
LAML	DFS	Tertile	All	0.140	0.582	.020	18	view →
KIRC	DFS	Tertile	All	0.196	0.627	.032	12	view →
ESCA	DFS	Tertile	III,IV	1.000	0.279	.034	12	view →
GBM	OS	Tertile	All	0.099	0.413	.029	9	view →
PRAD	OS	Tertile	All	0.491	0.893	.001	6	view →
SKCM	DFS	Tertile	III,IV	0.823	0.569	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-1236P–STAD (OS)

Open the STAD breakdown →